MarketInOut Stock Screener Log In | Sign Up
 

Edesa Biotech Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 08/26/2026 16:00
Edesa Biotech Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization42.71 mln
Float5.58 mln
Earnings Date12/11/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

16 / 100
Significantly lagging

Debt / Equity

0.00
Debt-free

ROE

-118
Deeply negative

Dividend Yield

0.00%
No dividend

DPS

0.00
No dividend

Business Description

Edesa Biotech is a Canadian biopharmaceutical company focused on developing treatments for inflammatory and immune-related conditions, with a pipeline that includes both injectable antibody therapies and topical creams. Its most advanced programs target serious conditions such as acute respiratory distress syndrome, chronic skin allergies, and pulmonary fibrosis, with several candidates already in late-stage clinical trials. The company works alongside research partners in Switzerland and Israel to broaden the reach of its drug development efforts across human and animal health applications. Founded in 2015 and based in Markham, Ontario, Edesa continues to advance its portfolio from early research through to potential commercialization.

Key Fundamentals

EPS-1.72
ROE-118
ROIC-708
ROA-103
EBITDA, mln-14.00
EV / EBITDA-3.61
EV / EBIT-3.58

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio3.09
Short % of Float2.42

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -14.09% 3 / 100   
1 Month -0.6% 28 / 100   
2 Months -58.66% 4 / 100   
6 Months 263% 99 / 100   
1 Year 104% 94 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us